Market Research Reports- Consulting Analysis Crystal Market Research Metabolomics Market by Technique and Application - | Page 2
High performance liquid chromatography (HPLC) segment occupied the largest share of metabolomics
market in 2016 and is expected to maintain its dominance during forecast period. This can be attributed to
number of factors such as high speed and accuracy of technique. Biomarker discovery segment occupied
the largest share of the overall market in 2016, due to factors such as enhancement in effectiveness and
reliability of metabolic profiling of biomarkers for drug discovery and diagnosing malfunction
metabolites.
U.S. accounted for the major share of the North American metabolomics market in 2016, owing to factors
such as easy availability of technologically advanced products, rise in adoption rate of personalized
medicines, and highly developed healthcare infrastructure. Emerging markets such as China and India
will exhibit favorable growth during the forecast period with rising emphasis on biopharmaceutical
research and development activities in these countries.
Key players in the global metabolomics market include LECO Corporation, Agilent Technologies, Inc.,
Waters Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Shimadzu Corporation,
Human Metabolome Technologies, Inc., Metabolon, Inc. and Bruker Corporation. Product development is
the key strategy adopted by the major players operating in the global market to expand and strengthen
their product portfolio and increase their market share. For instance, in May 2016,Agilent Technologies
Inc. introduced The Agilent 5110 ICP-OES to its lineup of inductively coupled plasma-optical emission
spectrometers. This new system will facilitate more accurate ICP-OES analysis.Likewise, in November
2016, Metabolon, Inc. launched the Meta IMD test that speeds up the diagnosis of inherent metabolic
disorders.
Request a sample copy of Metabolomics Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0635
Key Findings of the Research Study:
HPLC segment held the largest share of the global metabolomics market in 2016, owing to
accuracy and reliability of the technique.
Biomarker discovery segment held the major share of the metabolomics market in 2016, owing to
the high efficiency of metabolic biomarkers for managing diseases at the metabolic level.
North America held around two-fifth of the global share of the overall market in 2016, due to rise
in adoption rate of personalized medicines and easy access to technologically advanced products.
Asia-Pacific market is projected to grow with the highest CAGR over the forecast period as a
result of rise in age related disorders and prevalence of high unmet medical needs.
Inquire more about this report at: http://www.crystalmarketresearch.com/send-an-
enquiry/HC0635